PMID- 30865925 OWN - NLM STAT- MEDLINE DCOM- 20200721 LR - 20200901 IS - 1479-6821 (Electronic) IS - 1351-0088 (Print) IS - 1351-0088 (Linking) VI - 26 IP - 5 DP - 2019 May TI - Parental obesity programs pancreatic cancer development in offspring. PG - 511-523 LID - 10.1530/ERC-19-0016 [doi] LID - ERC-19-0016.R1 AB - Epidemiological studies suggest that timing of obesity onset - and underlying metabolic dysfunction - is important in determining pancreatic cancer rates: early and young adult abdominal overweight/obesity is more strongly associated with this cancer than obesity that develops later in life. Parental obesity and overweight are associated with metabolic dysfunction and obesity in their children. Here, we evaluated the impact of parental overweight on offspring's susceptibility of pancreatic cancer using the P48Cre/+/KrasG12D/+ mouse model. Male mice were fed an obesity-inducing diet (OID) before conception and mated with females raised on a control diet (CO) to generate the offspring. In a separate experiment, pregnant dams were fed CO or OID throughout gestation. The resulting OID offspring from the maternal (OID-m) or paternal lineage (OID-p) were used to study body weight, metabolic parameters and pancreatic cancer development and for molecular analysis. Parental obesity increased offspring's body weight at birth, weaning and in adulthood compared to CO, with gender- and genotype-specific differences. OID-p and OID-m offspring showed metabolic disorder and accelerated development of high-grade PanIN/PDAC. OID offspring also had higher rates of acinar-to-ductal reprogramming assessed by CPA1+/SOX9+-positive pancreatic cells. Levels of Tenascin C (TNC), an ECM glycoprotein shown to suppress apoptosis, were elevated in OID offspring, particularly females. In line with that, OID offspring displayed increased collagen content and decreased apoptosis in pancreatic lesions compared to CO. An ancestral history of obesity through either the paternal or maternal lineages increases offspring's susceptibility to pancreatic cancer development. FAU - da Cruz, Raquel Santana AU - da Cruz RS FAU - Clarke, Johan AU - Clarke J FAU - Curi, Ana Cristina P AU - Curi ACP FAU - Al-Yawar, Aseel AU - Al-Yawar A FAU - Jin, Lu AU - Jin L FAU - Baird, Ali AU - Baird A FAU - Cruz, M Idalia AU - Cruz MI FAU - Kallakury, Bhaskar AU - Kallakury B FAU - de Assis, Sonia AU - de Assis S LA - eng GR - K22 CA178309/CA/NCI NIH HHS/United States GR - P30 CA051008/CA/NCI NIH HHS/United States GR - UL1 TR001409/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - England TA - Endocr Relat Cancer JT - Endocrine-related cancer JID - 9436481 RN - EC 3.6.5.2 (Hras protein, mouse) RN - EC 3.6.5.2 (Proto-Oncogene Proteins p21(ras)) SB - IM MH - Animals MH - Animals, Newborn MH - Diet, High-Fat/adverse effects MH - Female MH - Male MH - *Maternal Nutritional Physiological Phenomena MH - Mice MH - Mutation MH - Obesity/*complications/pathology MH - Overweight/*complications/pathology MH - Pancreatic Neoplasms/etiology/*pathology MH - Proto-Oncogene Proteins p21(ras)/genetics MH - Weight Gain PMC - PMC6717698 MID - NIHMS1524245 OTO - NOTNLM OT - developmental programming OT - obesity OT - pancreatic cancer COIS- Declaration of interest: The authors have no conflicts of interest to declare. EDAT- 2019/03/14 06:00 MHDA- 2020/07/22 06:00 PMCR- 2020/09/01 CRDT- 2019/03/14 06:00 PHST- 2019/03/06 00:00 [received] PHST- 2019/03/13 00:00 [accepted] PHST- 2019/03/14 06:00 [pubmed] PHST- 2020/07/22 06:00 [medline] PHST- 2019/03/14 06:00 [entrez] PHST- 2020/09/01 00:00 [pmc-release] AID - ERC-19-0016.R1 [pii] AID - 10.1530/ERC-19-0016 [doi] PST - ppublish SO - Endocr Relat Cancer. 2019 May;26(5):511-523. doi: 10.1530/ERC-19-0016.